Infectious Disease

As the prevalence of pneumonia affects a variety of patient populations, it's imperative for health care professionals to stay current on changing guidelines.

The combination of emtricitabine/tenofovir alafenamide did not show a treatment benefit over comparator therapies.

Early treatment for HIV and tuberculosis found to improve outcomes.

Study targets how HIV avoids immune system defenses.

Researchers seek to develop drugs that block the Nef protein that is associated with HIV progressing to AIDS.

Researchers explore harnessing power of immune system to kill HIV.

HIV-positive men were more likely to have increased levels of inflammatory biomarkers than HIV-negative men.

School-based health services provide critical preventive care for adolescents, especially in poor and diverse communities.

Research analyzes HIV-positive individuals who naturally produce broadly neutralizing antibodies.

Simian immunodeficiency virus may be able to infect human cells.

Through a shell company, a New York pharmacist improperly billed Medicaid and others $274 million for illegally obtained HIV drugs.

Many conventional tests unable to detect resistance to antiretroviral drugs for HIV.

Athletes from a variety of sports dealt with the hardships of diseases treated by specialty pharmacy.

Anti-PD-1 antibodies produced more activated antiviral cells to attack HIV.

HIV screenings at home and immediate administration of antiretroviral therapy in HIV-positive patients shows promise.

It was previously believed that HIV-related brain inflammation may prevent Alzheimer’s disease.

Chimeric antigen receptors, typically studied for cancer immunotherapy, may treat HIV.

Researchers seek to eliminate HIV reservoirs with antiretroviral therapy.

Once-daily dose prevented vaginal and oral HIV transmission in animal models.

Viral suppression may translate to safe sex among couple with an HIV positive individual.

Top news of the day from across the health care landscape.

Researchers seek to induce broadly neutralizing antibodies to block numerous HIV variants.

New class of HIV medications called viral-entry inhibitors protect healthy cells from viral infection.

HIV infection rate among gay and bisexual men remains a problem.

Growing HIV incidence in young individuals could cause epidemic to become worse.